MX2022004147A - Novedosas composiciones de vacunas. - Google Patents

Novedosas composiciones de vacunas.

Info

Publication number
MX2022004147A
MX2022004147A MX2022004147A MX2022004147A MX2022004147A MX 2022004147 A MX2022004147 A MX 2022004147A MX 2022004147 A MX2022004147 A MX 2022004147A MX 2022004147 A MX2022004147 A MX 2022004147A MX 2022004147 A MX2022004147 A MX 2022004147A
Authority
MX
Mexico
Prior art keywords
vaccine compositions
novel vaccine
subserotype
antigen
shigella flexneri
Prior art date
Application number
MX2022004147A
Other languages
English (en)
Inventor
Laura Bartle Martin
Allan James Saul
Francesco Citiulo
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Publication of MX2022004147A publication Critical patent/MX2022004147A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6018—Lipids, e.g. in lipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se proporciona un antígeno O de Shigella flexneri de un primer serotipo o subserotipo para su uso en el aumento de una respuesta inmunitaria contra uno o más antígenos O de Shigella flexneri de un serotipo o subserotipo diferente, junto con restos de unión asociados, composiciones farmacéuticas, kits, usos o métodos.
MX2022004147A 2019-10-17 2020-10-15 Novedosas composiciones de vacunas. MX2022004147A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19203834.7A EP3808372A1 (en) 2019-10-17 2019-10-17 Novel vaccine compositions
PCT/EP2020/079140 WO2021074352A1 (en) 2019-10-17 2020-10-15 Novel vaccine compositions

Publications (1)

Publication Number Publication Date
MX2022004147A true MX2022004147A (es) 2022-07-19

Family

ID=68470230

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022004147A MX2022004147A (es) 2019-10-17 2020-10-15 Novedosas composiciones de vacunas.

Country Status (8)

Country Link
US (1) US20230263877A1 (es)
EP (2) EP3808372A1 (es)
JP (1) JP2022552352A (es)
CN (1) CN114786714A (es)
BR (1) BR112022006549A2 (es)
CA (1) CA3157885A1 (es)
MX (1) MX2022004147A (es)
WO (1) WO2021074352A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0917003D0 (en) 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Purification of bacterial vesicles
GB201017519D0 (en) * 2010-10-15 2010-12-01 Novartis Vaccines Inst For Global Health S R L Vaccines
IN2013DE01652A (es) * 2013-05-31 2015-06-26 Indian Council Medical Res
CN103966308B (zh) * 2013-12-31 2016-04-06 中国疾病预防控制中心传染病预防控制所 福氏志贺菌o-抗原3/4-o-乙酰化修饰检测试剂及其应用
EP4241851A3 (en) * 2015-06-16 2023-12-06 GlaxoSmithKline Biologicals SA Immunogenic compositions

Also Published As

Publication number Publication date
WO2021074352A1 (en) 2021-04-22
CN114786714A (zh) 2022-07-22
EP3808372A1 (en) 2021-04-21
BR112022006549A2 (pt) 2022-06-28
US20230263877A1 (en) 2023-08-24
JP2022552352A (ja) 2022-12-15
CA3157885A1 (en) 2021-04-22
EP4045079A1 (en) 2022-08-24

Similar Documents

Publication Publication Date Title
EA201990566A1 (ru) Композиции, содержащие бактериальные штаммы
PH12020500398A1 (en) Antibody-pyrrolobenzodiazepine derivative conjugate
CY1125211T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
SA517390513B1 (ar) تركيبات تشتمل على سلالات بكتيرية
MX2018001213A (es) Nuevos metodos para inducir una respuesta inmunitaria.
WO2018109170A3 (en) Il-11ra antibodies
SG10201803042PA (en) Anti-tim-3 antibodies
BR112016016580A2 (pt) Polissacarídeos capsulares de streptococcus pneumoniae e conjugados dos mesmos
BR112018012694A2 (pt) composição de célula dendrítica, vacina de célula dendrítica, composição e kit
MA52128A (fr) Compositions comprenant des souches bactériennes
WO2018161049A8 (en) Compositions and methods for inducing hiv-1 antibodies
MX2021003180A (es) Métodos y kits para preparar sangre entera con inactivación de patógenos.
WO2020131586A3 (en) Methods for identifying neoantigens
CY1123421T1 (el) Ενεργειακα ποτα και αλλα θρεπτικα βοηθηματα που προερχονται απο αλκοολουχα ποτα με βαση την αγαυη
EP4241851A3 (en) Immunogenic compositions
EA202190876A1 (ru) Композиции, содержащие бактериальные штаммы
EA202191631A1 (ru) Композиции, содержащие бактериальные штаммы
FI20165932L (fi) Immunomodulatorisia koostumuksia
MY186003A (en) Optical stack including reflective polarizer and compensation film
MX2022004147A (es) Novedosas composiciones de vacunas.
MX2021001888A (es) Composiciones que comprenden cepas bacterianas.
ZA202104747B (en) Novel trypanosomal vaccine
BR112017014842A2 (pt) composição de agente de formação de imagem, kit de agente de formação de imagem, e, método para preparação de uma composição de agente de formação de imagem
EP3897706A4 (en) COMPOSITIONS, METHODS AND USES FOR INDURING AN IMMUNE RESPONSE
WO2019036399A3 (en) METHOD OF CONTIGATION OF ANTIBODIES